← FDA Drug Approvals (Drugs@FDA)

CARBIDOPA AND LEVODOPA

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BIOCON PHARMA LIMITED · Approved 2025-12-04

Drug application

FDA Application #

ANDA220119

Application type

Abbreviated New Drug Application (Generic)

Brand name

CARBIDOPA AND LEVODOPA

Generic name

Carbidopa,Levodopa

Active ingredients

CARBIDOPA,LEVODOPA

Dosage form

CAPSULE, EXTENDED RELEASE

Route

—

Marketing status

None (Tentative Approval)

Sponsor

BIOCON PHARMA LIMITED

First approval

2025-12-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown